Anyone hoping for short- or medium-term reform of how Australia’s use of health technology assessment (HTA) incorporates patient perspectives could wait until the early 2030s.
Research grants on patient-informed decision-making, but patients need not apply
February 14, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 - - Latest News -
Tiny fragments of RNA, a giant opportunity for autoimmune disease treatment
February 10, 2026 - - Australian Biotech -
BCEC partners with Life Sciences Queensland to launch bursary for next-gen bio innovation leaders
February 10, 2026 - - Australian Biotech -
Memphasys fast-tracks Australian market entry with early TGA approval for Felix system
February 10, 2026 - - Australian Biotech -
Algorae expands commercial footprint with new licensing deal
February 10, 2026 - - Australian Biotech -
Immutep reaches midpoint in global Phase 3 lung cancer trial
February 10, 2026 - - Australian Biotech -
Molecule2Market appoints inaugural CEO to lead next phase of growth
February 10, 2026 - - Australian Biotech

